Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 022307102 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
FMR LLC
13G
|
5.5% |
8/6/2026
Event 6/30/2026
|
|
| FMR LLC | 5.5% | ||
| Abigail P. Johnson | 5.5% | ||
| BlackRock, Inc. 13G | 5.7% |
7/27/2026
Event 6/30/2026
|
|
|
AyurMaya Capital Management Company, LP
13D/A
Amendment 3
|
12.3% |
7/2/2026
Event 5/14/2026
|
|
| AyurMaya Capital Management Company, LP | 12.3% | ||
| David E. Goel | 12.3% | ||
|
Deep Track Capital, LP
13G
|
6.0% |
4/7/2026
Event 3/30/2026
|
|
| Deep Track Capital, LP | 6.0% | ||
| Deep Track Biotechnology Master Fund, Ltd. | 6.0% | ||
| David Kroin | 6.0% | ||
|
Foresite Capital Fund VI LP
13D/A
Amendment 4
|
12.7% |
4/3/2026
Event 4/1/2026
|
|
| Foresite Capital Fund VI LP | 3.4% | ||
| Foresite Capital Management VI, LLC | 3.4% | ||
| Foresite Capital Fund V, L.P. | 4.6% | ||
| Labs Co-Invest V, LLC | 0.2% | ||
| Foresite Capital Management V, LLC | 4.8% | ||
| Foresite Capital Opportunity Fund V, L.P. | 2.4% | ||
| Foresite Capital Opportunity Management V, LLC | 2.4% | ||
| Foresite Labs Fund I, L.P. | 1.6% | ||
| Foresite Labs Management I, LLC | 1.6% | ||
| Foresite Labs Affiliates 2021, LLC | 0% | ||
| Foresite Labs, LLC | 0% | ||
| James B. Tananbaum | 12.7% | ||
|
Samsara BioCapital, L.P.
13D/A
Amendment 1
|
5.4% |
1/13/2026
Event 1/9/2026
|
|
| Samsara BioCapital, L.P. | 3.8% | ||
| Samsara BioCapital GP, LLC | 3.8% | ||
| Samsara Opportunity Fund, L.P. | 1.6% | ||
| Samsara Opportunity Fund GP, LLC | 1.6% | ||
| Srinivas Akkaraju | 5.4% | ||
|
Foresite Capital Fund VI LP
13D/A
Amendment 3
|
14.1% |
1/12/2026
Event 1/8/2026
|
|
| Foresite Capital Fund VI LP | 3.7% | ||
| Foresite Capital Management VI, LLC | 3.7% | ||
| Foresite Capital Fund V, L.P. | 5.0% | ||
| Labs Co-Invest V, LLC | 0.2% | ||
| Foresite Capital Management V, LLC | 5.1% | ||
| Foresite Capital Opportunity Fund V, L.P. | 2.5% | ||
| Foresite Capital Opportunity Management V, LLC | 2.5% | ||
| Foresite Labs Fund I, L.P. | 1.7% | ||
| Foresite Labs Management I, LLC | 1.7% | ||
| Foresite Labs Affiliates 2021, LLC | 1.0% | ||
| Foresite Labs, LLC | 1.0% | ||
| James B. Tananbaum | 14.1% | ||
|
Samsara BioCapital, L.P.
13D
|
5.3% |
11/24/2025
Event 11/18/2025
|
|
| Samsara BioCapital, L.P. | 4.6% | ||
| Samsara BioCapital GP, LLC | 4.6% | ||
| Samsara Opportunity Fund, L.P. | 0.7% | ||
| Samsara Opportunity Fund GP, LLC | 0.7% | ||
| Srinivas Akkaraju | 5.3% | ||
|
Samsara BioCapital, L.P.
13D/A
Amendment 2
|
4.9% |
11/17/2025
Event 11/13/2025
|
|
| Samsara BioCapital, L.P. | 4.6% | ||
| Samsara BioCapital GP, LLC | 4.6% | ||
| Samsara Opportunity Fund, L.P. | 0.3% | ||
| Samsara Opportunity Fund GP, LLC | 0.3% | ||
| Srinivas Akkaraju | 4.9% | ||
|
venBio Global Strategic Fund IV, L.P.
13G/A
Amendment 1
|
4.8% |
11/17/2025
Event 6/30/2025
|
|
| venBio Global Strategic Fund IV, L.P. | 4.8% | ||
| venBio Global Strategic GP IV, LLC | 4.8% | ||
| Adelman Robert J | 4.8% | ||
| Goodman Corey S | 4.8% | ||
|
Foresite Capital Fund VI LP
13D/A
Amendment 2
|
15.9% |
6/10/2025
Event 5/21/2025
|
|
| Foresite Capital Fund VI, L.P. | 4.4% | ||
| Foresite Capital Management VI, LLC | 4.4% | ||
| Foresite Capital Fund V, L.P. | 5.8% | ||
| Labs Co-Invest V, LLC | 0.2% | ||
| Foresite Capital Management V, LLC | 6.0% | ||
| Foresite Capital Opportunity Fund V, L.P. | 2.1% | ||
| Foresite Capital Opportunity Management V, LLC | 2.1% | ||
| Foresite Labs Fund I, L.P. | 2.0% | ||
| Foresite Labs Management I, LLC | 2.0% | ||
| Foresite Labs Affiliates 2021, LLC | 1.2% | ||
| Foresite Labs, LLC | 1.2% | ||
| James B. Tananbaum | 15.9% | ||
|
Samsara BioCapital, L.P.
13D/A
Amendment 1
|
5.0% |
5/23/2025
Event 5/21/2025
|
|
| Samsara BioCapital, L.P. | 5.0% | ||
| Samsara BioCapital GP, LLC | 5.0% | ||
| Srinivas Akkaraju | 5.0% | ||
|
AyurMaya Capital Management Company, LP
13D/A
Amendment 2
|
15.8% |
5/23/2025
Event 5/21/2025
|
|
| AyurMaya Capital Management Company, LP | 15.8% | ||
| David E. Goel | 15.8% | ||
|
Foresite Capital Fund VI LP
13D/A
Amendment 1
|
32.2% |
5/7/2025
Event 8/13/2024
|
|
| Foresite Capital Fund VI, L.P. | 9.0% | ||
| Foresite Capital Management VI, LLC | 9.0% | ||
| Foresite Capital Fund V, L.P. | 11.8% | ||
| Labs Co-Invest V, LLC | 0.4% | ||
| Foresite Capital Management V, LLC | 12.2% | ||
| Foresite Capital Opportunity Fund V, L.P. | 4.3% | ||
| Foresite Capital Opportunity Management V, LLC | 4.3% | ||
| Foresite Labs Fund I, L.P. | 4.2% | ||
| Foresite Labs Management I, LLC | 4.2% | ||
| Foresite Labs Affiliates 2021, LLC | 2.5% | ||
| Foresite Labs, LLC | 2.5% | ||
| James B. Tananbaum | 32.2% | ||
|
AyurMaya Capital Management Company, LP
13D/A
Amendment 1
|
22.5% |
2/10/2025
Event 2/6/2025
|
|
| AyurMaya Capital Management Company, LP | 22.5% | ||
| David E. Goel | 22.5% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 5 | 10.1 k | $74.9 k |
| 2026 Q2 | 213 | 120 M | $3.40 B |
| 2026 Q1 | 214 | 115 M | $2.53 B |
| 2025 Q4 | 143 | 79.1 M | $771 M |
| 2025 Q3 | 138 | 63.1 M | $252 M |
| 2025 Q2 | 124 | 78.3 M | $235 M |
| 2025 Q1 | 73 | 40.2 M | $247 M |
| 2024 Q4 | 66 | 40.3 M | $317 M |
| 2024 Q3 | 55 | 35.2 M | $376 M |
| 2024 Q2 | 31 | 29.0 M | $385 M |